AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
5min chapter
What Clinicians Want to Know About the Management of Relapsed/Refractory Mantle Cell Lymphoma
Hematologic Oncology Update
New Trials and Phase 1/2 Data in the Management of Relapsed/Refractory Mantle Cell Lymphoma
This chapter explores two trials comparing BR to Zanu retuximab in the management of mantle cell lymphoma, discussing response rates, toxicity, and selectivity of the drugs.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode